Wellington Management Group
INBX icon

Wellington Management Group’s Inhibrx INBX Stock Holding History

Wellington Management Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03M Sell
21,421
-4,364
-17% -$437K ﹤0.01% 1618
2026
Q1 		$1.73M Sell
25,785
-2,608
-9% -$193K ﹤0.01% 1580
2025
Q4 		$2.24M Sell
28,393
-1,366
-5% -$93.1K ﹤0.01% 1574
2025
Q3 		$1M Buy
+29,759
New +$733K ﹤0.01% 1776
2024
Q3 		– Sell
-31,678
Closed -$449K – 1968
2024
Q2 		$449K Buy
+31,678
New +$495K ﹤0.01% 1786

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group's INBX Position: Q2 2026 in Review

Wellington Management Group reduced its Inhibrx (INBX) stake by 17% in Q2 2026, selling an estimated $437K and leaving 21,421 shares worth $2.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1618.

Wellington Management Group first reported a position in INBX in Q2 2024 and has held it in 5 quarters since. The position peaked at $2.24M in Q4 2025. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Wellington Management Group held 21,421 shares of Inhibrx worth $2.03M as of Q2 2026.
  • Wellington Management Group sold 4,364 Inhibrx shares in Q2 2026, an estimated $437K.
  • Inhibrx made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1618 holding.
  • Wellington Management Group first reported a position in Inhibrx in Q2 2024 and has held it in 5 quarters since.
  • Wellington Management Group's Inhibrx position peaked at $2.24M in Q4 2025.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.